The point you raise around alopecia is an interesting one. Especially around breast cancer. On the table above, Zantrene shows 83% of patients having zero to mild hair loss. Yet Dox had 74% of patients having moderate to severe hair loss. I imagine if those historical results are shared with women in the breast cancer trials, that alone would significantly improve our patient take-up. There’s an entire industry catering to cancer treatment wigs for women and anything we can do to help the emotional side of treatment would be a huge psychological win, let alone the obvious medical benefits of Zantrene
General Comments / Chat, page-7527
-
- There are more pages in this discussion • 3,762 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.60 |
Change
0.035(2.24%) |
Mkt cap ! $267.5M |
Open | High | Low | Value | Volume |
$1.58 | $1.64 | $1.55 | $104.5K | 65.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 370 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 3503 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 370 | 1.585 |
1 | 1050 | 1.580 |
2 | 2550 | 1.575 |
2 | 21050 | 1.570 |
2 | 1901 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.595 | 3503 | 2 |
1.600 | 6559 | 2 |
1.605 | 419 | 1 |
1.610 | 410 | 1 |
1.630 | 3461 | 4 |
Last trade - 14.42pm 15/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online